The properties of intestinal bacteria/probiotics, such as cell surface hydrophobicity (CSH), auto-aggregation, and biofilm formation ability, play an important role in shaping the relationship between the bacteria and the host. The current study aimed to investigate the cell surface properties of fish intestinal bacteria and probiotics. Microbial adhesion to hydrocarbons was tested according to Kos and coauthors. The aggregation abilities of the investigated strains were studied as described by Collado and coauthors. The ability of bacterial isolates to form a biofilm was determined by performing a qualitative analysis using crystal violet staining based on the attachment of bacteria to polystyrene. These studies prove that bacterial cell surface hydrophobicity (CSH) is associated with the growth medium, and the effect of the growth medium on CSH is species-specific and likely also strain-specific. Isolates of intestinal lactobacilli from fish (Salmo ischchan) differed from isolates of non-fish/shrimp origin in the relationship between auto-aggregation and biofilm formation. Average CSH levels for fish lactobacilli and E. coli might were lower compared to those of non-fish origin, which may affect the efficiency of non-fish probiotics use in fisheries due to the peculiarities of the hosts’ aquatic lifestyles.

No abstract

Scientific data suggests the possible beneficial role of probiotics in treatments for COVID-19, but the species/strains-specificity and disease-specificity of probiotics need high attention in choosing the appropriate probiotic in diseases, in particularly in the COVID-19. We hope this review will raise awareness of the COVID-19 probiotic recommendations, highlighting the latest scientific information about virus/hydrogen peroxide/probiotics and the importance of finding out of a specific “criterion” for the probiotics’ recommendation in this disease.

In recent years, the use of probiotics has increased unprecedently, regardless of their origin and characteristics. In particular, the use of probiotics for nutritional and therapeutic purposes in infants and patients with a number of diseases (malignant neoplasms, diabetes, post-transplant period, etc.) needs reviews and clinical justification. Currently, in the production of dairy products, lactic acid bacteria (LAB) of intestinal origin are of particular interest, which is explained by the fact that the final target of probiotics is the intestine of an animal or a person. However, there is some skepticism about the efficacy of using human gut-derived LABs in dairy production. LABs are widespread in nature: exist in large quantities in plant residues, soil, human and animal intestines. LABs are widely used both in health care and agriculture, as well as in fisheries and fish production. A task was set up to study a series of biosafety indicators of yoghurts obtained from the Lpb. plantarum ZPZ, Lcb. rhamnosus str. Vahe.am, Lpb. plantarum K1-3, L. delbrueckii IAHAHI probiotic strains. Yoghurts produced with biosafety indicators corresponding to the risk of spreading antibiotic resistance in yoghurts, heavy metals and M1 aflatoxin content, as well as to international standards for microbiological indicators were obtained from new probiotics isolated from the intestinal microbiota of children (Lpb. plantarum ZPZ, Lcb. rhamnosus str. Vahe) and dairy products (Lpb. plantarum K1-3, L. delbrueckii IAHAHI). The results of our research prove that yoghurts obtained from lactic acid bacteria of different origins are harmless to health.